Sphera Funds Management Ltd. Gossamer Bio, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $410,550 - $1.02 Million	-805,000 Reduced 78.37%	222,134 $199,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $248,764 - $469,543	-310,956 Reduced 23.24%	1,027,134 $1.21 Million
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $285,349 - $642,036	-594,478 Reduced 30.76%	1,338,090 $1.22 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $1.51 Million - $3.52 Million	1,932,568 New	1,932,568 $1.6 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $78.9M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.